Protective effects of cyclohexyladenosine following cerebral ischemia in the gerbil hippocampus.
Daval
J L
JL
Unit on Neurochemistry, BPB, National Institute of Mental Health, Bethesda, MD 20892.
von Lubitz
D K
DK
Deckert
J
J
Marangos
P J
PJ
D000241:Adenosine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D002545:Brain Ischemia / Q000378:metabolism* / Q000473:pathology; D005576:Colforsin / Q000378:metabolism*; D005849:Gerbillinae; D006160:Guanosine Triphosphate / Q000031:analogs & derivatives*; D006165:Guanylyl Imidodiphosphate / Q000378:metabolism*; D006624:Hippocampus / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D011897:Random Allocation; D011983:Receptors, Purinergic / Q000032:analysis / Q000378:metabolism*; D013997:Time Factors
D011983:Receptors, Purinergic; D005576:Colforsin; D006165:Guanylyl Imidodiphosphate; C027513:N(6)-cyclohexyladenosine; D006160:Guanosine Triphosphate; D000241:Adenosine